Saba Capital Management »

Arbutus Biopharma shares owned by Saba Capital Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 651k 3.09
2024-03-31 $964k 374k 2.58

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Gabelli Dividend & Income Trust (GDV)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Neuberger Berman Next Genera Common Stock (NBXG)
American Airls Put Option (AAL)
Invesco Van Kampen Muni Opp Trust (VMO)

View all positions for Saba Capital Management

Top funds holding Arbutus Biopharma

Morgan Stanley
Whitefort Capital Management
BlackRock
BlackRock
Two Seas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
BlackBarn Capital Partners
Rubric Capital Management
Squarepoint Ops
Advisor Group Holdings
Northern Trust
Charles Schwab Investment Management
Hudson Bay Capital Management

View all funds holding Arbutus Biopharma